SCHEMBL687724

SCHEMBL687724

CCCc1cn(Cc2c(Cl)cccc2OCC)c(=O)c(NC(=O)N[C@@H](CC(=O)O)c2cccc(OCC)c2)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
FFAR1 O14842 2/20 0.35
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PTGER3 P43115 2/20 0.33
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP1A2 P05177 1/20 0.32
CTSA P10619 1/20 0.32
POLB P06746 1/20 0.32
KCNB1 Q14721 1/20 0.32
CYP3A4 P08684 1/20 0.31
CASP1 P29466 2/20 0.31
CASP3 P42574 2/20 0.31
CASP7 P55210 2/20 0.31
CASP8 Q14790 2/20 0.31
CNR1 P21554 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688582 0.96 SMN1; SMN2 (0.39) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL688419 0.95 SMN1; SMN2 (0.35) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL688331 0.95 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL686761 0.94 SMN1; SMN2 (0.37) SMN1; SMN2KDM4EALDH1A1KMT2ANPSR1
SCHEMBL27741947 0.92 SMN1; SMN2 (0.41) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL687970 0.92 SMN1; SMN2 (0.41) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL687713 0.91 CTSA (0.37) SMN1; SMN2KDM4EALDH1A1KMT2ANPSR1
SCHEMBL687881 0.91 PTGER3 (0.40) FFAR1PTGER3NPSR1RXFP1CYP1A2
SCHEMBL686989 0.91 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1KDM4EALDH1A1PTGER3
SCHEMBL687913 0.90 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1PTGER3KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed